Vaxart Expands Intellectual Property Portfolio With European Patent Protecting Proprietary Norovirus Vaccine Technology
VXRT•Reuters brief
Vaxart Inc. said it has expanded its intellectual property portfolio with a European patent protecting its proprietary norovirus vaccine technology.
